Dianthus Therapeutics (DNTH) PT Raised to $110 at Truist Securities

March 9, 2026 7:26 AM

Truist Securities analyst Danielle Brill raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $110.00 (from $63.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found